Beside the experimental data, the authors investigated periostin in clinical settings and found the progressive elevation of its levels as the disease evolves from MGUS, SMM (smoldering multiple myeloma), and symptomatic MM [32]. This evidence concerns the gene POSTN and Miyoshi myopathy.